Want to join the conversation?
$ACET said that its subsidiary, Rising Pharmaceuticals, is launching an FDA-approved generic version of $GSK's Avodart (Dutasteride) Softgel Capsules 0.5 mg in the U.S. market. According to IMS Health, U.S. market for Dutasteride, which is used for the treatment of symptomatic BPH in men with enlarged prostate, is about $452MM.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.